This is a great read (thanks to the wonderful Lisa M on the pickyeatingadults forum for reposting it).
At this year’s Eating Disorders: State of the Art Treatment 2016 symposium in Baltimore on April 9th, our number one supporter Dr. Nancy Zucker will be presenting The Phenomenology and Management of Aviodant/Restrictive Food Intake Disorder (ARFID) and a subsequent breakout session. While this is not the kind of talk a typical ARFIDer might attend and find helpful, it’s still a great day for ARFIDers because it means more and more health professionals will be educated on our behalf. Thank you Dr. Zucker for spreading the word. It’s a marvelous thing.
As I’ve dove into finding stories of others who have had success improving their ARFID I’ve noticed that pretty much everyone has had to try numerous methods to help introduce new foods to their diet. There’s no one method that’s worked for everyone. I’m wondering if the timing of the therapy is as, if not more, important than the therapy itself. Is it possible that no matter how beneficial a treatment could be, if our minds and bodies are not ready for change than maybe none will happen? It took me three tries with hypnotherapy before it started working for me. Why didn’t it work the first two? Would other therapies have worked in those two cases? I have no idea. Its just my opinion but I think there needs to be an alignment between trying a therapy and being ready to succeed.
This is an interesting article from the New York Times that doesn’t specifically mention ARFID but points out how there are many ‘for profit’ treatment centers for Eating Disorders popping up. What’s really concerning is when those centers become “business models” and are purchased by private equity groups who are less interested in helping patients than making a higher rate of return on their investment. I’m not trying to discourage ARFIDers from considering these but please do your research before investing in a treatment.
This is an inspiring success story. Go McKaelen!
This is a pretty good one. Although I’d like to know their source on why they think exposure-response prevention is showing promise.